| Nasal allergies in the Latin American population: results from the Allergies in Latin America survey. | |
| | |
MedLine Citation:
|
PMID: 20557683 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Allergies in Latin America is the first cross-national survey that describes the symptoms, impact, and treatment of nasal allergies (NAs) in individuals >or=4 years old in Latin America (LA). In total, 22,012 households across the Latin American countries of Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, and Venezuela were screened for children, adolescents, and adults with a diagnosis of NA and either symptoms or treatment in the past 12 months. A total of 1088 adults and 457 children and adolescents were included and the sample was probability based to ensure valid statistical inference to the population. Approximately 7% of the LA population was diagnosed with NAs with two of three respondents stating that their allergies were seasonal or intermittent in nature. A general practice physician or otolaryngologist diagnosed the majority of individuals surveyed. Nasal congestion was the most common and bothersome symptom of NAs. Sufferers indicated that their symptoms affected productivity and sleep and had a negative impact on quality of life. Two-thirds of patients reported taking some type of medication for their NAs, with a roughly equal percentage of patients reporting taking over-the-counter versus prescription medications. Changing medications was most commonly done in those reporting inadequate efficacy. The most common reasons cited for dissatisfaction with current medications were related to inadequate effectiveness, effectiveness wearing off with chronic use, failure to provide 24-hour relief, and bothersome side effects (e.g., unpleasant taste and retrograde drainage into the esophagus). Findings from this cross-national survey on NAs have confirmed a high prevalence of physician-diagnosed NAs and a considerable negative impact on daily quality of life and work productivity as well as substantial disease management challenges in LA. Through identification of disease impact on the LA population and further defining treatment gaps, clinicians in LA may better understand and treat NAs, thus leading to improvements in overall patient satisfaction and quality of life. |
| | |
Authors:
|
Hugo Neffen; Joao F Mello; Dirceu Sole; Charles K Naspitz; Alberto Eduardo Dodero; Héctor León Garza; Edgard Novelo Guerra; Carlos Baez-Loyola; John M Boyle; Mark A Wingertzahn |
Related Documents
:
|
12465203 - Office workers and video display terminals: physical, psychological and ergonomic factors. 17377613 - Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (bp... 11549633 - Use of a parenteral propylene glycol-containing etomidate preparation for the long-term... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-06-16 |
Journal Detail:
|
Title: Allergy and asthma proceedings : the official journal of regional and state allergy societies Volume: 31 Suppl 1 ISSN: 1539-6304 ISO Abbreviation: Allergy Asthma Proc Publication Date: 2010 May-Jun |
Date Detail:
|
Created Date: 2010-07-09 Completed Date: 2010-10-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9603640 Medline TA: Allergy Asthma Proc Country: United States |
Other Details:
|
Languages: eng Pagination: S9-27 Citation Subset: IM |
Affiliation:
|
Respiratory Medicine Unit, Children's Hospital Orlando Alassia, Santa Fe, Argentina. hugoneffen@arnet.com.ar |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Anti-Allergic Agents / adverse effects, therapeutic use Child Data Collection Humans Latin America / epidemiology Patient Satisfaction Quality of Life Rhinitis, Allergic, Perennial / diagnosis*, epidemiology, therapy* Rhinitis, Allergic, Seasonal / diagnosis*, epidemiology, therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Allergic Agents |
| Comments/Corrections | |
Comment In:
|
Allergy Asthma Proc. 2010 May-Jun;31 Suppl 1:S5-7
[PMID:
20615312
]
Allergy Asthma Proc. 2010 May-Jun;31 Suppl 1:S3 [PMID: 20615311 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: How can we inprove the management of allergic rhinitis in Latin America?
Next Document: Ciclesonide, a hypotonic intranasal corticosteroid.